Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3630824 Title: COMPOSITIONS BIOPHARMACEUTIQUES ET PROCÉDÉS ASSOCIÉS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
187324884
WO application number:
IB2018053683
Type:
European patent granted for BE
Status:
Open
Publication number:
3630824
WO publication number:
WO2018215964
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
24/05/2018
Grant date:
22/04/2026
EP publication date:
08/04/2020
WO publication date:
29/11/2018
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
22/04/2026
EP B1 publication date:
22/04/2026
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
24/05/2038

Applicant

Name:
GlaxoSmithKline Intellectual Property Development Limited
Legal Form:
From:
22/04/2026
Address:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom (GB)
To:

Inventor

1

Name:
GRANT, Steven
Legal Form:
Address:
Stevenage Hertfordshire SG 1 2NY, United Kingdom (GB)

2

Name:
AKINSEYE, Chika
Legal Form:
Address:
Stevenage Hertfordshire SG12NY, United Kingdom (GB)

3

Name:
BHINDER, Tejinder
Legal Form:
Address:
Stevenage Hertfordshire SG12NY, United Kingdom (GB)

4

Name:
HOOK, Laura
Legal Form:
Address:
Stevenage Hertfordshire SG12NY, United Kingdom (GB)

5

Name:
LEWIS, Alan Peter
Legal Form:
Address:
Stevenage Hertfordshire SG12NY, United Kingdom (GB)

6

Name:
ORECCHIA, Martin
Legal Form:
Address:
Hitchin SG4 9NH, United Kingdom (GB)

Priority

Priority patent number:
201762511441 P
Priority date:
26/05/2017
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 39/00; A61P 11/00; A61P 17/00; A61P 11/06; A61K 39/395; C07K 16/24;

Publication

European Patent Bulletin

Issue number:
202617
Publication date:
22/04/2026
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
22/06/2026
Annual fee number:
9
Annual fee amount:
165 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type